George H. Perkins, MD

Department of Breast Radiation Oncology, Division of Radiation Oncology

About Dr. George H. Perkins

Dr. Perkins is a Professor in the Department of Radiation Oncology at The University of Texas M D Anderson Cancer Center. He is also the Chief Medical Officer and Medical Director of Physician Referral Service and Physician Referral Service Administrative Services (the Faculty Practice Plan of UT MDACC). He is a clinician and researcher specializing in breast cancer as well as Health Related Quality of Life and Quality of Care. He also is comprehensively trained in Outcomes Analyses, Patient-reported outcomes (related to population-based healthcare and systems delivery), and healthcare costs. Dr. Perkins is a member of the Psychosocial Behavioral and Health Services Research Core and the Patient Reported Outcomes Core at M D Anderson. He is the developer of a prospective patient reported HRQOL instrument that has helped to identify opportunities for healthcare and patient care improvement in breast cancer that lead to interventions that improve the standards of care. One of these interventions is a NCI R01 grant phase III randomized trial. Dr. Perkins is committed to patient-centered cost-effective care and to improving the standards of care. His specific interests and expertise include: breast cancer during pregnancy, pregnancy associated breast cancer, male breast cancer, breast cancer in young women, breast cancer in African American women, inoperable and recurrent breast cancer, and special/atypical types or presentations of breast cancer. Internationally, Dr. Perkins is a member of the International Society for Quality of Life Research and the International Psycho-Oncology Society. Nationally, he serves on the Radiation Therapy Oncology Group committees for Health Services Research, Outcomes, Technology Assessment, Quality of Life, Government Relations, and Minority and Special Populations. Locally, he serves on the U T System Insurance Advisory Board and MD Anderson Physician Relations Advisory Board. He also serves on the Executive Committee of the Medical Staff and the Institutional Audit Committee. Lastly, and most important to his patients, Dr. Perkins is a Best Doctor Award Recipient since 2005, Top Doctor Award Recipient since 2007, Patient Choice Award Recipient since 2012, recipient of the Delclos Excellence in Teaching Award, M D Anderson Outstanding Educator Award, and has twice received the NIH National Research Service Award.

Primary Appointment

Adjunct Professor, Medical Dosimetry and Radiation Therapy and Technology, The University of Texas MD Anderson Cancer Center School of Health Professions, Houston, TX

Chief Medical Officer, Physicians Referral Service and Physicians Referral Service Administrative Services, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Medical Director, Physicians Referral Service and Physicians Referral Service Administrative Services, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Professor, Medical Dosimetry and Radiation Therapy and Technology, The University of Texas MD Anderson Cancer Center School of Health Professions, Houston, TX

Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1993	University of North Carolina School of Medicine, Chapel Hill, North Carolina, US, MD
1988	University of North Carolina School of Public Health, Chapel Hill, North Carolina, US, Public Health, BSPH
1987	Wake Forest University, Winston - Salem, North Carolina, US, Medical Sciences, BS

Postgraduate Training

2012-2013	Certificate in Academic Medical Leadership, The Texas Medical Center and The University of Texas School of Public Health, Houston, Texas
2007-2008	Certificate in Clinical Safety and Effectiveness, The University of Texas M D Anderson Cancer Center, Houston, Texas
2006-2007	Certificate in Leadership, The University of Texas M D Anderson Cancer Center, Houston, Texas
1999-2000	Post-Doctoral Fellowships in Outcomes Research and Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1995-1999	Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1994-1995	Internship, Mayo Clinic and Graduate School of Medicine, Jacksonville, FL, Rochester, MN, Transitional Surgery and Medicine, Mayo Clinic and Graduate School of Medicine, Rochester, Minnesota
1993-1994	Post-Doctoral Research Fellowship Award, Lineberger Comprehensive Cancer Center Fellowship in Cancer Cell Biology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Licenses & Certifications

2023	Washington State Department of Health
2023	Arizona Board of Medical Examiners
2023	Georgia Composite Medical Board
2023	Louisiana State Board of Medical Examiners
2023	Tennessee Board of Medical Examiners
2023	Mississippi State Board of Medical Licensure
2023	Oklahoma State Board of Medical Licensure
2023	Alabama Board of Medical Examiners
2021	Florida Board of Medicine
2019	DEA
2000	Texas Medical Board Physician Permit
1999	The American Board of Radiology

Experience & Service

Faculty Academic Appointments

Associate Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2014

Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2007

Administrative Appointments/Responsibilities

Chief Medical Officer, Physicians Referral Service and Physicians Referral Service Administrative Services, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2025

Medical Director, Physicians Referral Service and Physicians Referral Service Administrative Services, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - Present

Teaching Assistant Biochemistry, Gross Anatomy, Pathology, Microbiology, School of Medicine, University of North Carolina, Chapel Hill, NC, 1989 - 1991

Director, Science Outreach Programs, North Carolina Museum of Life and Science, Durham, NC, 1987 - 1988

Special Assistant to Dean for Business Affairs, Duke University, Fuqua School of Business, Durham, NC, 1985 - 1987

Other Professional Positions

Member, Committee on Cancer, Texas Medical Association, Austin, TX, 2019 - Present

Member, Committee on National Quality Programs and Clinical Measures, Texas Medical Association, Houston, TX, 2019 - Present

Member, Committee on Healthcare Quality, Texas Medical Association, Houston, TX, 2019 - Present

Member, Legislative Affairs Committee, Texas Medical Association, Houston, TX, 2019 - Present

Co-Lecturer on Healthcare Costs and Value-based Healthcare delivery, Texas Medical Center Healthcare Policy Institute, Houston, TX, 2017 - Present

Course Advisor, Curriculum on Healthcare Reform, Management, and Costs, Rice University Jones School of Business, Houston, TX, 2017 - Present

Co Chairman ; Innovation in Healthcare Conference, Texas Medical Center, Houston, TX, 2017 - Present

Governing Board Member; Healthcare Innovation Center, Texas Medical Center, Houston, TX, 2017 - Present

Member of the Board, Academic Medical Leadership Program, Texas Medical Center, Houston, TX, 2016 - Present

Member, Executive Advisory Board, University of Texas School of Public Health Fleming Management Institute, Houston, TX, 2016 - Present

Advisor, Working Group for UT System Health Component Integration, The University of Texas System, Austin, TX, 2016 - Present

Member, Advisory group on Healthcare Policy and Reform, Rice University Baker Institute for Public Policy, Houston, TX, 2014 - Present

Member, Faculty Productivity Working Group, The University of Texas System, Austin, TX, 2012 - Present

Member, System Meaningful Use EMR, Health IT Executive Committee, The University of Texas System, Austin, TX, 2011 - Present

Member, System Wide Insurance Advisory Committee, The University of Texas System, Austin, TX, 2009 - Present

Member, Managed Care Contract Audit Committee (A-Team), The University of Texas System, Austin, TX, 2009 - Present

Chairman, Radiation Physics Course Committee, Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 2009 - Present

Member, Faculty Practice By-Law Committee, The University of Texas System, Austin, TX, 2008 - Present

Member, Technology Assessment Task Force, American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Therapeutic Radiology and Oncology, Fairfax, VA, 2002 - 2007

Member, Health Services research Committee, American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Therapeutic Radiology and Oncology, Fairfax, VA, 2002 - 2007

Member, Coordinating Committee, Council on Medical Subspecialty Societies, American Board of Medical Subspecialty Societies, N/A, 2001 - Present

Member, Outcomes Committee, Radiation Therapy Oncology Group, (RTOG), Radiation Therapy Oncology Group, Philadelphia, PA, 2001 - Present

Member, Quality of Life Committee, Radiation Therapy Oncology Group, (RTOG), Radiation Therapy Oncology Group, Philadelphia, PA, 2001 - Present

Member, Minority and Special Populations Committee, Radiation Therapy Oncology Group (RTOG), Radiation Therapy Oncology Group, Philadelphia, PA, 2001 - Present

Member, Working Group on Radiation Oncology Late Effects and Normal Tissue Tolerance (LENTT), American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Therapeutic Radiology and Oncology, Fairfax, VA, 2001 - 2010

Member, Executive Board, Young Members Section, American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Therapeutic Radiology and Oncology, Fairfax, VA, 2001 - 2007

Member, Outcomes Committee, American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Therapeutic Radiology and Oncology, Fairfax, VA, 2001 - 2007

Member, New Investigators Committee, Radiation Therapy Oncology Group, (RTOG), Radiation Therapy Oncology Group, Philadelphia, PA, 2001 - 2007

Member, Working Group for the Center for Research on Minority Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - Present

Member, Working Group for Evaluating Research on Breast Cancer in African-American Women, unknown, unknown, 2000 - Present

Member, Government Relations Committee, American Society for Therapeutic Radiology and Oncology (ASTRO), American Society for Therapeutic Radiology and Oncology, Fairfax, VA, 1996 - Present

Member, Executive Board Committee, Association of Residents in Radiation Oncology, (ARRO), Association of Residents in Radiation Oncology, Fairfax, VA, 1996 - 2000

Member, Residency Review Committee, (ACGME), Accreditation Council for Graduate Medical Education, Chicago, IL, 1996 - 2000

Member, Residency Review Committee, Association of Residents in Radiation Oncology, (ARRO), Association of Residents in Radiation Oncology, Fairfax, VA, 1996 - 2000

Trustee- at- Large, National Board of Trustees, American Medical Student Association, Reston, VA, 1991 - 1993

Speaker of the House of Delegates, American Medical Student Association, Reston, VA, 1991 - 1993

Extramural Institutional Committee Activities

Core member and Task force member, Operational Priority on Education, The University of Texas MD Anderson Cancer Center, 2017 - Present

Core member and Task Force member, Operational Priority on Financial Sustainability, The University of Texas MD Anderson Cancer Center, 2017 - Present

Vice-Chair, Office of Health Policy Advisory Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

Member, Public Reporting Governance Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

Chairman, Medicare MACRA Steering Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present

Co-Chair, Strategic Goals Committee on Room Utilization, The University of Texas MD Anderson Cancer Center, 2014 - Present

Chair, Ad Hoc Committee on Institutional Budget Reform, The University of Texas MD Anderson Cancer Center, 2014 - Present

Chair, Cancer Network Integration and Compensation Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2017

Vice-Chair, Reimbursement and Revenue Denials Prevention Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present

Member, Faculty Percent Effort Standardization Ad Hoc Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2014

Board Member, Physicians Relations Advisory Board, The University of Texas MD Anderson Cancer Center, 2013 - Present

Chair, Hassenbusch Leadership and Institutional Service Award Committee, The University of Texas MD Anderson Cancer Center, 2012 - Present

member, Faculty Recognition/Incentive Program Ad Hoc Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2014

Member/Champion, ICD-10 Executive Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present

member, Medicare Executive Electronic Health Records Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present

Physicians Referral Service Representative, Productivity Work Group, The University of Texas MD Anderson Cancer Center, 2011 - Present

Permanent Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2010 - Present

member, Institutional Audit Committee, The University of Texas MD Anderson Cancer Center, 2010 - Present

member, Charles LeMaistre Award Selection Committee, The University of Texas MD Anderson Cancer Center, 2010 - Present

member, Physicians Referral Service Professional Affairs Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present

Vice-Chair, Physicians Referral Service Retirement Board, The University of Texas MD Anderson Cancer Center, 2009 - Present

Vice-Chair, Physicians Referral Service Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present

member, Physicians Referral Service Executive Council, The University of Texas MD Anderson Cancer Center, 2009 - Present

Vice-Chair, Physicians Referral Service Faculty Compensation and Benefits Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present

member, Institutional Compliance and Ethics Committee, The University of Texas MD Anderson Cancer Center, 2009 - Present

Faculty Senate Representative, MDACC Strategic Planning Committee for Research, The University of Texas MD Anderson Cancer Center, 2009 - 2010

Member, Breast Tissue Oversight Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2009

Member, Convocation Speakers Selection Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present

Member, Faculty Achievement Awards Selection Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2010

Member, Vice-President Search Committee, Department of Human Resources, The University of Texas MD Anderson Cancer Center, 2007 - 2008

Member, Oversight and Strategic Planning, Quality of Life Core Facility PROSPR Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present

Member, Faculty Appeals and Grievance Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present

Member/Reviewer, Tumor Bank Steering Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2010

Member, Faculty Compensation Committee, The University of Texas MD Anderson Cancer Center, 2006 - Present

Member, Faculty Senate By-Laws Committee, The University of Texas MD Anderson Cancer Center, 2006 - Present

Member, Executive Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, 2006 - 2010

Member, Executive Committee, Global Oncology Oversight/Steering Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2011

Member, Oversight and Strategic Planning, Global Academic Programs Oversight Steering Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2011

Alternate Member, Tumor Bank Steering Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2007

Member, Quality of Life Advisory Committee, The University of Texas MD Anderson Cancer Center, 2005

Member, Faculty Senate Clinical Affairs Committee, The University of Texas MD Anderson Cancer Center, 2004 - Present

Member, Faculty Senate Finance Committee, The University of Texas MD Anderson Cancer Center, 2004 - Present

Vice-Chair, Physician’s Referral Service (PRS) Budget and Finance Committee, The University of Texas MD Anderson Cancer Center, 2004 - Present

Member, Psychosocial Behavioral Science Health Services Research IRB, The University of Texas MD Anderson Cancer Center, 2004 - 2007

Senator, Faculty Senate representing Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2003 - 2010

Member, Bioterrorism Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2005

Member, Psychosocial Behavioral Health Services Research (IRB) Committee, The University of Texas MD Anderson Cancer Center, 2002 - 2004

Member, Infection Control Committee, The University of Texas MD Anderson Cancer Center, 2001 - 2007

Co-Chairman, Quality of Education Committee, The University of Texas MD Anderson Cancer Center, 1998 - 1999

Honors & Awards

2017 - 2024	Top 1% Patient Experience Award, M D Anderson Cancer Center Physician Referral Service
2012	Outstanding Educator of the Month, University of Texas MD Anderson Cancer Center
2008 - 2024	Best Doctors in Cancer, Best Doctors Incorporated
2008 - 2024	Top Doctor, Castle Connolly Medical Ltd
2007 - 2024	America's Top Radiologists (Radiation Oncology), Consumer Research Council of America
2007 - 2024	Outstanding Health Professionals Worldwide, International Centre, Cambridge, England
2005 - 2024	Best Doctors In America, Best Doctors, Incorporated
2005	Luis Delclos Excellence in Teaching Award, The University of Texas M. D. Anderson Cancer Center
1999	Chairman, Quality of Education Committee (Chief Resident), The University of Texas M. D. Anderson Cancer Center
1999	National Research Service Award, The University of Texas M. D. Anderson Cancer Center
1996	Berlex Oncology Foundation Award
1995	American Medical Association/Glaxo Wellcome Residency Achievement Award, American Medical Association/Glaxo Wellcome
1993	Christopher C. Fordham III Leadership Award, Univ. of North Carolina, School of Medicine
1993	Lineberger Comprehensive Cancer Center Award, Univ. of North Carolina, School of Medicine
1992	Medical Foundation Board of Directors Merit Award, Univ. of North Carolina, School of Medicine
1991	Distinguished Medical Scholars Award, Univ. of North Carolina, School of Medicine
1990	Warwick Fellowship Award, Univ. of North Carolina School of Medicine, Great Britain National Public Health Service
1989	William B.D. MacNider Award, Univ. of North Carolina, School of Medicine
1988	Chancellor’s Scholar Award, Univ. of North Carolina, School of Medicine
1988	Delta Omega Honor Society Award, Univ. of North Carolina, School of Public Health

Professional Memberships

American Psychosocial Oncology Society

2015 - Present

American College of Physician Executives

2012 - Present

American Brachytherapy Society

2011 - Present

American Society of Breast Disease

2011 - Present

The University of Texas Faculty Association

2010 - Present

International Psycho-Oncology Society

2000 - Present

American Society for Clinical Oncology

2000 - Present

American Society of Clinical Pathologists

2000 - Present

International Society for Quality of Life Research

2000 - Present

International Society for Quality of Life Studies

2000 - 2006

Radiation Therapy Oncology Group (RTOG)

1999 - 2010

Texas Medical Association

1995 - Present

American Society for Therapeutic Radiology and Oncology (ASTRO)

1995 - Present

Harris County Medical Society

1995 - Present

Texas Radiological Society

1995 - 2006

American College of Radiology

1995 - 2006

American College of Radiation Oncology

1995 - 2006

Association of Residents in Radiation Oncology (ARRO)

1995 - 2000

American Medical Association

1994 - Present

American Medical Student Association

1988 - 1993

Selected Presentations & Talks

Local Presentations

2007. Radiation for DCIS: What are the sutdies needed to advance the field?. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.

National Presentations

2018. Healthcare Policy Controversies: Miracles, Mergers, MACRA, and Measures. Invited. 16th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
2016. Regional Nodal Irradiation: Results from recently reported clinical trials. Invited. 14th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
2014. Poster: Toward developing survivorship care plans for breast cancer patients at high risk for radiation-related cardiac effects. Invited. ASTRO 2014. San Francisco, CA, US.
2014. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at 6 months compared to conventionally fractionated whole breast irradiation: results of a randomized trial. Invited. ASTRO 2014. San Francisco, CA, US.
2013. POSTER: Prospective phase II study of concurrent Capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer. Invited. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
2012. Management of breast cancer: Self-assessment module (SAM). Invited. RadOnc 2012. Houston, TX, US.
2010. Electron conformal therapy in breast cancer. Invited. Spring 2010 Compensator-Based IMRT Symposium. Orlando, FL, US.
2010. Breast Cancer - Partial breast irradiation - when is it appropriate?. Invited. RadOnc 2010. Houston, TX, US.
2006. Poster - Psychosocial outcomes for survivors of male breast cancer. Invited. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
2006. Mucinous breast carcinoma: outcomes data very favorable histology?. Invited. American Society for Therapeutic Radiology and Oncology, 48th Annual Meeting. Philadelphia, PA, US.
2006. Poster - A cost-effectiveness analysis of raloxifene in the prevention of invasive breast cancer in women treated for Hodgkin's disease. Invited. 1st Annual American Society for Therapeutic Radiology and Oncology Health Services Research Symposium. San Diego, CA, US.
2006. Poster - Randomized trial of yoga in women with breast cancer undergoing radiation treatment. Invited. American Psychosomatic Society conference. Denver, CO, US.
2005. Poster - Tubular carcinoma: outcomes analysis of favorable breast cancer treated with breast conserving therapy. Invited. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
2004. State-of-the-Art Breast Irradiation – The Anderson Technique. Invited. RadOnc 2004. Houston, TX, US.
2003. Thymic neoplasms: An outcomes analysis of 78 patients treated at MD Anderson Cancer Center. Invited. 85th Annual Meeting of the American Radium Society. Houston, TX, US.
2003. The addition of chemotherapy to surgery or radiation improves outcome in the treatment of invasive thymoma. Invited. Annual Meeting of the American Radium Society. Houston, TX, US.
2002. Male breast carcinoma: outcomes and predictors of local-regional failure in patients treated without radiation therapy. Poster Discussion Presentation. Invited. 25th Annual San Antonio Breast Cancer Symposium. San Antonio, TX, US.

International Presentations

2011. Personalized Radiation therapy in breast cancer. Invited. 2011 Internationl Symposium on Breast Cancer Prevention Research and Treatment. Tianjin, CN.
2011. Yoga improves QOL, cortisol rhythm, and HRV for women with breast cancer undergoing radiotherapy. Invited. American Society of Clinical Oncology. Chicago, US.
2005. Randomized trial of yoga in women with cancer. Invited. International Yoga Conference. Bangalore, IN.
2005. Randomized trial of yoga in women with breast cancer undergoing radiation treatment. Invited. The 2nd International Conference of the Society of Integrative Oncology. San Diego, US.
2003. A population-based analysis of male breast cancer: Outcomes and care patterns of the SEER data. Poster discussion. Invited. 39th Annual Meeting of the American Society of Clinical Oncology. Chicago, US.
2002. Gliomatosis Cerebri: Improved Outcome with Radiation Therapy Platform Presentation. Invited. 82nd Annual Meeting of the American Radium Society. London, EC.

Formal Peers

2015. Patient Reported Outcomes of Breast Cancer Treatment : Improving care by Listening. Visiting. Winston-Salem, NC, US.
2015. The Challenging Role of Measures in Value based Healthcare Delivery. Visiting. Winston-Salem, NC, US.
2011. Health related QUality of Life in Breast Cancer Treatment. Visiting. Tianjin, CN.
2011. Radiation Management of the Axilla in Breast Cancer. Visiting. Tianjin, CN.

Less

Grant & Contract Support

Date:	2025 - 2030
Title:	Biobehavioral Effects of a Tele-Health Comprehensive Yoga Therapy Intervention for Overweight Woman with Breast Cancer
Funding Source:	NIH/NCI
Role:	Co-PI

Date:	2020 - 2021
Title:	Product Development of Intensity Modulation for Bolus Electron Conformal Therapy
Funding Source:	Dot Decimal Inc
Role:	Co-I
ID:	FP00007960

Date:	2020 - 2023
Title:	Telemedicine Access for Cancer Patients
Funding Source:	Blue Cross and Blue Shield of Texas
Role:	PI
ID:	LS2020-00058719-HM

Date:	2020 - 2023
Title:	Mobile-Health Delivery of Integrative Medicine Lifestyle Interventions for Breast Cancer Patients During Community Isolation for the COVID-19 Pandemic
Funding Source:	GATEWAY FOR CANCER RESEARCH
Role:	Key

Date:	2020 - 2023
Title:	Mobile-Health Delivery of a Comprehensive Lifestyle Intervention for Overweight Women with Breast Cancer: Mechanisms and Biobehavioral Outcomes
Funding Source:	GATEWAY FOR CANCER RESEARCH
Role:	Collaborator

Date:	2019 - 2021
Title:	Product Development of Intensity Modulation for Bolus Electron Conformal Therapy
Funding Source:	Dot Decimal Inc
Role:	Co-I
ID:	CA199838

Date:	2019 - 2022
Title:	Telemedicine in Oncology Care: Optimizing Costs, Quality, and Utilization of services
Funding Source:	Health Care Services Corporation/ Affordability Cures Research Consortium
Role:	PI
ID:	HCSC HSRUTG3

Date:	2017 - 2022
Title:	Biobehavioral Effects of Yoga versus CBSM for Women with Breast Cancer Experiencing Depressive Symptoms and Undergoing Radiotherapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	00017004

Date:	2015 - 2018
Title:	Precision radiation therapy system for advanced permanent interstitial brachytherapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-Program Leader
ID:	DP150018

Date:	2014 - 2017
Title:	Yoga for women with breast cancer undergoing radiotherapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5R01CA1398800-05

Date:	2010 - 2017
Title:	Yoga-based intervention for women with breast cancer undergoing radiotherapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	NCI R01 CA138800-01

Date:	2005 - 2007
Title:	Biobehavioral effects of yoga for Cancer Patients
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	CA 102385

Date:	2005 - 2008
Title:	Burden of breast cancer related lymphedema on working American families
Funding Source:	American Cancer Society (ACS)
Role:	Co-I

Date:	2004 - 2005
Title:	Psychobehavioral status and HRQOL of Male Breast Cancer Survivors
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	CA57730

Date:	2000 - 2002
Title:	Breast Cancer Survivors, Physical Activity, and QOL
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	CA 89519

Date:	2000 - 2003
Title:	Computer Aided Stress Reduction, Mental Health and Cancer
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	MH/CA 62031

Title:	Supporting and Sustaining Behavior Change in Overweight Women with Breast Cancer: Biobehavioral Effects and Mechanisms of a Comprehensive Telehealth Lifestyle Intervention
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	FP00017029

Selected Publications

Peer-Reviewed Articles

Perkins GH. Cost Utility Analysis Alongside a Randomized Trial of Tibetan Yoga in Patients with Breast Cancer Undergoing Chemotherapy. Cancer. e-Pub 2026.
Liu X, Cohen L, Chaoul A, Arun B, Basen-Engquist K, Perkins GH, Valero V, Rinpoche TW, Li Y, Shih YT. Cost Utility Analysis Alongside a Randomized Trial of Tibetan Yoga in Patients with Breast Cancer Undergoing Chemotherapy". Journal of the National Cancer Institute. e-Pub 2026.
Powers-James C, Christie AJ, Arun B, Austin T, Basen-Engquist K, Carmack C, Chaoul A, Newton LC, Haddad R, Harrison C, Li Y, Mallaiah S, Nagarathna R, Parker P, Perkins G, Spelman A, Sood A, Wagner R, Yang P, Yeung SJ, Cohen L. Lifestyle Program for Breast Cancer Improves Body Composition, Fitness, and Patient-Reported Outcomes: A Randomized Clinical Trial. Cancers, 2026. e-Pub 2026.
Powers-James, C, Christie, AJ, Arun, BK, Austin, T, Babiera, G, Basen-Engquist, KM, Carmack, CL, Chaoul, MA, Connelly Newton, L, Haddad, R, Harrison, CA, Leung, CH, Li, Y, Mallaiah, S, Nagarathna, R, Parker, PA, Perkins, GH, Spelman, AR, Sood, AK, Wagner, R, Yang, P, Yeung, SJ, Cohen, L. Lifestyle Program for Breast Cancer Improves Body Composition, Fitness, and Patient-Reported Outcomes. Cancers 18(11), 2026. e-Pub 2026. PMID: 42279341.
Li Y, Cohen L, Basen-Engquist K, Arum B, Perkins G, Valero V, Chaoul A, Shih YT. A Cost Benefit Analysis of a Lifestyle program to Improve Patient reported Outcomes in Breast Cancer: Can we afford not to implement what works?. Journal of Clinical Oncology. e-Pub 2026.
Middleton, LP, Perkins, GH, Whitman, GJ, Mouabbi, JA, Bevers, TB, Yi, M, Hunt, KK. Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ. Breast Cancer Research and Treatment 213(2):225-235, 2025. e-Pub 2025. PMID: 40637967.
Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
Maroongroge S, De B, Woodhouse KD, Bassett RL, Lee P, Bloom ES, Smith GL, Frank SJ, Li J, Perkins G, Das P, Koong AC, Smith BD, Wang C. Physician Perspectives on Telemedicine in Radiation Oncology. Adv Radiat Oncol 8(2):101005, 2023. e-Pub 2023. PMID: 36311822.
Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 195(1):33-41, 2022. e-Pub 2022. PMID: 35816269.
Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2022. e-Pub 2022. PMID: 35387420.
Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. Int J Radiat Oncol Biol Phys 112(2):426-436, 2022. e-Pub 2022. PMID: 34610390.
Chapman BV, Liu D, Shen Y, Olamigoke OO, Lakomy DS, Barrera AMG, Stecklein SR, Sawakuchi GO, Bright SJ, Bedrosian I, Litton JK, Smith BD, Woodward WA, Perkins GH, Hoffman KE, Stauder MC, Strom EA, Arun BK, Shaitelman SF. Breast radiotherapy-related treatment outcomes in patients with or without germline mutations on multigene panel testing. Int J Radiat Oncol Biol Phys 112(2):437-444, 2022. e-Pub 2022. PMID: 34582940.
Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
Devlin L, Okletey J, Perkins G, Bowen JR, Nakos K, Montagna C, Spiliotis ET. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells. Proteomics, 2021. e-Pub 2021. PMID: 34409731.
Pasalic D, Strom EA, Allen PK, Williamson TD, Poenisch F, Amos RA, Woodward WA, Stauder MC, Shaitelman SF, Smith BD, Perkins GH, Tereffe W, Hoffman KE. Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase II Trial. Int J Radiat Oncol Biol Phys 109(2):441-448, 2020. e-Pub 2020. PMID: 32946965.
Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
Christopherson KM, Lei X, Barcenas CH, Buchholz TA, Garg N, Hoffman K, Kuerer HM, Mittendorf EA, Perkins G, Shaitelman SF, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward W, Smith BD. Outcomes of curative-intent treatment for breast cancer patients presenting with sternal or mediastinal involvement. Int J Radiat Oncol Biol Phys. e-Pub 2019. PMID: 30851348.
Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol:JCO1800317. e-Pub 2018. PMID: 30379626.
Van Wyhe RD, Caudle AS, Shaitelman SF, Perkins GH, Buchholz TA, Hoffman KE, Strom EA, Smith BD, Tereffe W, Woodward WA, Stauder MC. A Component of Lobular Carcinoma in Clinically Lymph Node-Negative Patients Predicts for an Increased Likelihood of Upstaging to Pathologic Stage III Breast Cancer". Adv Radiat Oncol 3(3):252-257, 2018. e-Pub 2018. PMID: 30197937.
Ovalle V, Strom EA, Shaitelman S, Hoffman K, Amos R, Perkins G, Tereffe W, Smith BD, Stauder M, Woodward W. Proton partial breast irradiation: Detailed description of acute clinico-radiologic effects. Cancers (Basel) 10(4), 2018. e-Pub 2018. PMID: 29642467.
Chaoul A, Milbury K, Spelman A, Basen-Engquist K, Hall MH, Wei Q, Shih YT, Arun B, Valero V, Perkins GH, Babiera GV, Wangyal T, Engle R, Harrison CA, Li Y, Cohen L. Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy. Cancer 124(1):36-45, 2018. e-Pub 2018. PMID: 28940301.
Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K, Smith BD, Buchholz TA, Perkins GH. A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 99(4):777-783, 2017. e-Pub 2017. PMID: 28843370.
Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol. e-Pub 2017. PMID: 28766219.
Milbury K, Kavanagh A, Meng Z, Chen Z, Chandwani KD, Garcia K, Perkins GH, McQuade J, Raghuram NV, Nagarathna R, Liao Z, Nagendra HR, Chen J, Guo X, Liu L, Arun B, Cohen L. Depressive symptoms and positive affect in Chinese and United States breast cancer survivors: a cross-cultural comparison. Support Care Cancer. e-Pub 2017. PMID: 28233122.
Arun B, Austin T, Babiera GV, Basen-Engquist K, Carmack CL, Chaoul A, Cohen L, Connelly L, Haddad R, Harrison C, Li Y, Mallaiah S, Nagarathna R, Parker PA, Perkins GH, Reuben JM, Shih YT, Spelman A, Sood A, Yang P, Yeung SJ. A Comprehensive Lifestyle Randomized Clinical Trial: Design and Initial Patient Experience. Integr Cancer Ther. e-Pub 2016. PMID: 27903842.
Lu Q, You J, Kavanagh A, Warmoth K, Meng Z, Chen Z, Chandwani KD, Perkins GH, McQuade JL, Raghuram NV, Nagarathna R, Liao Z, Nagendra HR, Chen J, Guo X, Liu L, Arun B, Cohen L. Differences in quality of life between American and Chinese breast cancer survivors. Support Care Cancer 24(9):3775-82, 2016. e-Pub 2016. PMID: 27048455.
Ratcliff CG, Milbury K, Chandwani KD, Chaoul A, Perkins G, Nagarathna R, Haddad R, Nagendra HR, Raghuram NV, Spelman A, Arun B, Wei Q, Cohen L. Examining Mediators and Moderators of Yoga for Women With Breast Cancer Undergoing Radiotherapy. Integr Cancer Ther 15(3):250-62, 2016. e-Pub 2016. PMID: 26867802.
Torfeh T, Hammoud R, Perkins G, McGarry M, Aouadi S, Celik A, Hwang KP, Stancanello J, Petric P, Al-Hammadi N. Characterization of 3D geometric distortion of magnetic resonance imaging scanners commissioned for radiation therapy planning. Magn Reson Imaging 34(5):645-53, 2016. e-Pub 2016. PMID: 26795695.
Pan HY, Shaitelman SF, Perkins GH, Schlembach PJ, Woodward WA, Smith BD. Implementing a Real-Time Electronic Data Capture System to Improve Clinical Documentation in Radiation Oncology. J Am Coll Radiol 13(4):401-7, 2016. e-Pub 2016. PMID: 26681164.
Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol. e-Pub 2015. PMID: 26247543.
Strom EA, Amos RA, Shaitelman SF, Kerr MD, Hoffman KE, Smith BD, Tereffe W, Stauder MC, Perkins GH, Amin MD, Wang X, Poenisch F, Ovalle V, Buchholz TA, Babiera G, Woodward WA. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol 5(4):e283-90, 2015. e-Pub 2015. PMID: 25804105.
Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus 4:36, 2015. e-Pub 2015. PMID: 25674496.
Shaitelman SF, Buchholz TA, Hunt KK, Hortobagyi GN, Schlembach P, Arzu I, Bloom E, Chronowski G, Dvorak T, Grade E, Hoffman KE, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Smith BD. Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compated to conventionally fractionated whole breast irradiation: results of a randomized Trial. Int J Radiat Oncol Biol Phys 90(5):1264, 2014. e-Pub 2014. PMID: 25539386.
Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med 174(9):1450-9, 2014. e-Pub 2014. PMID: 25023650.
Yang J, Woodward WA, Reed VK, Strom EA, Perkins GH, Tereffe W, Buchholz TA, Zhang L, Balter P, Court LE, Li XA, Dong L. Statistical modeling approach to quantitative analysis of interobserver variability in breast contouring. Int J Radiat Oncol Biol Phys 89(1):214-221, 2014. e-Pub 2014. PMID: 24613812.
Chandwani KD, Perkins G, Nagendra HR, Raghuram NV, Spelman A, Nagarathna R, Johnson K, Fortier A, Arun B, Wei Q, Kirschbaum C, Haddad R, Morris GS, Scheetz J, Chaoul A, Cohen L. Randomized, controlled trial of yoga in women with breast cancer undergoing radiotherapy. J Clin Oncol 32(10):1058-65, 2014. e-Pub 2014. PMID: 24590636.
MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE. Therapeutic radiation dose delivered to the low axilla during whole breast radiotherapy in the prone posistion: implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-122, 2014. e-Pub 2014. PMID: 24890352.
Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus 3:166, 2014. e-Pub 2014. PMID: 24711988.
Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?. Br J Radiol 86(1029):20130176, 2013. e-Pub 2013. PMID: 23728947.
Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortobágyi GN, Theriault RL. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist 18(4):369-76, 2013. e-Pub 2013. PMID: 23576478.
Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 83(4):1089-94, 2012. e-Pub 2012. PMID: 22172912.
Wang X, Pan T, Pinnix C, Zhang SX, Salehpour M, Sun TL, Gladish G, Strom EA, Perkins GH, Tereffe W, Woodward W, Hoffman KE, Buchholz TA, Yu TK. Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 82(2):708-14, 2012. e-Pub 2012. PMID: 21444161.
Kim MM, Kudchadker RJ, Kanke JE, Zhang S, Perkins GH. Bolus electron conformal therapy for the treatment of recurrent inflammatory breast cancer: a case report. Med Dosim 37(2):208-13, 2012. e-Pub 2012. PMID: 21978532.
Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TK. Local-Regional Recurrence With and Without Radiation Therapy after Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3n0 Breast Cancer. Int J Radiat Oncol Biol Phys 81(3):782-7, 2011. e-Pub 2011. PMID: 21885207.
Reddy JP, Levy L, Oh JL, Strom EA, Perkins GH, Buchholz TA, Woodward WA. Long-Term Outcomes in Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer. Int J Radiat Oncol Biol Phys 80(5):1453-1457, 2011. e-Pub 2011. PMID: 21168284.
Wang X, Amos RA, Zhang X, Taddei PJ, Woodward WA, Hoffman KE, Yu TK, Tereffe W, Oh J, Perkins GH, Salehpour M, Zhang SX, Sun TL, Gillin M, Buchholz TA, Strom EA. External-Beam Accelerated Partial Breast Irradiation Using Multiple Proton Beam Configurations. Int J Radiat Oncol Biol Phys 80(5):1464-1472, 2011. e-Pub 2011. PMID: 20708848.
Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat 128(2):421-7, 2011. e-Pub 2011. PMID: 21553292.
Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP. Clinical Implications of Margin INvolvement by Pleomorphic Lobular Carcinoma In Situ. Arch Pathol Lab Med 135(6):737-743, 2011. e-Pub 2011. PMID: 21631266.
Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-6, 2010. e-Pub 2010. PMID: 20564117.
Woodward WA, Truong PT, Yu TK, Tereffe W, Oh J, Perkins G, Strom E, Meric-Bernstam F, Gonzalez-Angulo AM, Speers C, Ragaz J, Buchholz TA. Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival. Breast Cancer Res Treat 123(2):597-605, 2010. e-Pub 2010. PMID: 20306128.
Greenbaum MP, Strom EA, Allen PK, Perkins GH, Oh JL, Tereffe W, Yu TK, Buchholz TA, Woodward WA. Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy modified radical mastectomy, and post-mastectomy radiation. Radiother Oncol 95(3):312-6, 2010. e-Pub 2010. PMID: 20227126.
Dominici LS, Kuerer HM, Babiera G, Hahn KM, Perkins G, Middleton L, Ramirez MM, Yang W, Hortobagyi GN, Theriault RL, Litton JK. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. e-Pub 2010. PMID: 20519803.
Smith GL, Shih YC, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study. Cancer 116(3):734-41, 2010. e-Pub 2010. PMID: 20014181.
Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, Woodward WA, Perkins G, Buchholz TA, Strom EA. Clinically apparent internal mammary nodal metastasis in patients with advance breast cancer: Incidence and local control. Int J Radiat Oncol Biol Phys. e-Pub 2010. PMID: 20004535.
Chandwani KD, Thornton B, Perkins GH, Arun B, Raghuram NV, Nagendra HR, Wei Q, Cohen L. Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancer. J Soc Integr Oncol 8(2):43-55, 2010. e-Pub 2010. PMID: 20388445.
Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg 209(4):425-433.e2, 2009. e-Pub 2009. PMID: 19801315.
Ludwig MS, McNeese MD, Buchholz TA, Perkins GH, Strom EA. The lateral decubitus breast boost: description, rationale and efficacy. Int J Radiat Oncol Biol Phys 76(1):100-3. e-Pub 2009. PMID: 19394161.
Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, Oh JL, Yu TK, Bedrosian I, Whitman GJ, Buchholz TA, Dong L. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. Int J Radiat Oncol Biol Phys 73(5):1493-500, 2009. e-Pub 2009. PMID: 18804333.
Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a two-year follow-up study. J Clin Oncol 27(12):2007-2014, 2009. e-Pub 2009. PMID: 19289624.
Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 2009. e-Pub 2009. PMID: 18707822.
Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH. The impact of pregnancy on breast cancer outcomes in women
Garg AK, Frija EK, Sun TL, Strom EA, Perkins GH, Oh JL, Yu TK, Woodward WA, Tereffe WA, Salehpour M, Buchholz TA. Effects of Variable Placement of Superior Tangential/Supraclavicular Match Line on Dosimetric Coverage of Level III Axilla/Axillary Apex in Patients Treated with Breast and Supraclavicular Radiotherapy. Int J Radiat Oncol Biol Phys 73(2):370-4, 2009. e-Pub 2009. PMID: 18676090.
Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: State of the Science and Roadmap to Advance the Field. J Clin Oncol 27(2):279-88, 2009. e-Pub 2009. PMID: 19064970.
Mathew J, Perkins GH, Stephens T, Middleton LP, Yang WT. Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. AJR Am J Roentgenol 191(6):1631-9, 2008. e-Pub 2008. PMID: 19020230.
Gadre SA, Perkins GH, Sahin AA, Sneige N, Deavers MT, Middleton LP. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion. Histopathology 53(5):545-53, 2008. e-Pub 2008. PMID: 18983463.
Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional Treatment Outcomes After Multimodality Management Of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 2008. e-Pub 2008. PMID: 18439768.
De Giorgi U, Perkins GH, Cristofanilli M. Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual?. J Clin Oncol 26(24):4044-7, 2008. e-Pub 2008. PMID: 18711199.
Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation Use and Long-Term Survival in Breast Cancer Patients with T1, T2 Primary Tumors and One to Three Positive Axillary Lymph Nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 2008. e-Pub 2008. PMID: 18234447.
Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WA. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 71(2):435-40, 2008. e-Pub 2008. PMID: 18164831.
Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-9, 2008. e-Pub 2008. PMID: 18213620.
Woodward WA, Durand JB, Tucker SL, Strom EA, Perkins GH, Oh J, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral carotid stenosis after radiation noted. Cancer 112(2):268-73, 2008. e-Pub 2008. PMID: 18000801.
Garg AK, Oh JL, Oswald MJ, Huang E, Strom EA, Perkins GH, Woodward WA, Yu TK, Tereffe W, Meric-Bernstam F, Hahn K, Buchholz TA. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys 69(5):1478-83, 2007. e-Pub 2007. PMID: 17855016.
Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-7, 2007. e-Pub 2007. PMID: 17941034.
Liengsawangwong R, Yu TK, Sun TL, Erasmus JJ, Perkins GH, Tereffe W, Oh JL, Woodward WA, Strom EA, Salephour M, Buchholz TA. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 69(3):711-5, 2007. e-Pub 2007. PMID: 17889264.
Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 2007. e-Pub 2007. PMID: 17826073.
Middleton LP, Perkins GH, Tucker SL, Sahin AA, Singletary SE. Expression of ERalpha and ERbeta in lobular carcinoma in situ. Histopathology 50(7):875-80, 2007. e-Pub 2007. PMID: 17543077.
Borghero YO, Salehpour M, McNeese MD, Stovall M, Smith SA, Johnson J, Perkins GH, Strom EA, Oh JL, Kirsner SM, Woodward WA, Yu TK, Buchholz TA. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison. Radiother Oncol 82(3):324-8, 2007. e-Pub 2007. PMID: 17157944.
Garden AS, Morrison WH, Wong PF, Tung SS, Rosenthal DI, Dong L, Mason B, Perkins GH, Ang KK. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67(2):438-44, 2007. e-Pub 2007. PMID: 17141972.
Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2007. e-Pub 2007. PMID: 17236970.
Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Middleton L, Hahn K, Hortobagyi GN, Buchholz TA. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer 107(11):2662-8, 2006. e-Pub 2006. PMID: 17061247.
Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TA. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol 24(31):4971-5, 2006. e-Pub 2006. PMID: 17075114.
Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 66(2):352-7, 2006. e-Pub 2006. PMID: 16887286.
Yom SS, Morrison WH, Ang KK, Rosenthal DI, Perkins GH, Wong PF, Garden AS. Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66:469-76, 2006. e-Pub 2006. PMID: 16887292.
Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107:1219-26, 2006. e-Pub 2006. PMID: 16894524.
Oh JL, Bonnen M, Outlaw ED, Schechter NR, Perkins GH, Strom EA, Babiera G, Oswald MJ, Allen PK, Thames HD, Buchholz TA. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?. Int J Radiat Oncol Biol Phys 65(5):1345-52, 2006. e-Pub 2006. PMID: 16750315.
Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh J, Domain D, Yu TK, Woodward WA, Tereffe W, Singletary SE, Thomas E, Buzdar AU, Hortobagyi GN, McNeese MD. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 65(4):1155-60, 2006. e-Pub 2006. PMID: 16750325.
Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Adjuvant systemic therapy for male breast carcinoma. Cancer 104(11):2359-64, 2005. e-Pub 2005. PMID: 16270318.
Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63(5):1508-13, 2005. e-Pub 2005. PMID: 16169678.
Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Babiera G, Hunt KK, Hortobagyi GN, Buchholz TA. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol 28(5):485-94, 2005. e-Pub 2005. PMID: 16199989.
Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62(2):351-7, 2005. e-Pub 2005. PMID: 15890574.
Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy. Cancer 103(4):689-95, 2005. e-Pub 2005. PMID: 15641036.
Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22(23):4691-9, 2004. e-Pub 2004. PMID: 15570071.
Yu TK, Whitman GJ, Thames HD, Buzdar AU, Strom EA, Perkins GH, Schechter NR, McNeese MD, Kau SW, Thomas ES, Hortobagyi GN, Buchholz TA. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 96(22):1676-81, 2004. e-Pub 2004. PMID: 15547180.
Buchholz TA, Huang EH, Berry D, Pusztai L, Strom EA, McNeese MD, Perkins GH, Schechter NR, Kuerer HM, Buzdar AU, Valero V, Hunt KK, Hortobagyi GN, Sahin AA. Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 59(5):1337-42, 2004. e-Pub 2004. PMID: 15275718.
Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 101(1):51-7, 2004. e-Pub 2004. PMID: 15221988.
Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys 59(4):1074-9, 2004. e-Pub 2004. PMID: 15234041.
Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22(12):2303-12, 2004. e-Pub 2004. PMID: 15197191.
Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59(1):138-45, 2004. e-Pub 2004. PMID: 15093909.
Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100(3):490-8, 2004. e-Pub 2004. PMID: 14745864.
Woodward WA, Strom EA, McNeese MD, Perkins GH, Outlaw EL, Hortobagyi GN, Buzdar AU, Buchholz TA. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 57(2):327-35, 2003. e-Pub 2003. PMID: 12957242.
Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57(2):336-44, 2003. e-Pub 2003. PMID: 12957243.
Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21(17):3244-8, 2003. e-Pub 2003. PMID: 12947058.
Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 56(4):1137-46, 2003. e-Pub 2003. PMID: 12829152.
Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926-33, 2003. e-Pub 2003. PMID: 12569592.
Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera G, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese M, Strom E, Valero V, KK: H. Local control determines systemic recurrence and disease-specific survival after breast-conserving therapy. Cancer 97:926-33, 2003. e-Pub 2003.
Meric F, Mirza N, Vlastos G, Buchholz T, Kuerer H, Babiera G, Singletary S, Ross M, Ames F, Feig B, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt K. Impact of Positive Surgical Margins and Ipsilateral Breast Tumor Recurrence Predict Disease-Specific Survival after Breast-Conserving Therapy. The American Journal of Oncology Review 2(8):428-433, 2003. e-Pub 2003.
Huang E, McNeese MD, Strom EA, Perkins GH, Katz A, Hortobagyi GN, Valero V, Kuerer HM, Singletary SE, Hunt KK, Buzdar AU, Buchholz TA. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 53(5):1225-33, 2002. e-Pub 2002. PMID: 12128124.
Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9(6):543-9, 2002. e-Pub 2002. PMID: 12095969.
Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53(4):880-8, 2002. e-Pub 2002. PMID: 12095553.
Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, SL: T. Pathological factors that predict for local-regional recurrences after mastectomy are different for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int. J Rad Oncol Biol Phys 53:880-8, 2002. e-Pub 2002.
Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, Frye D, Strom EA, McNeese MD, Perkins G, Katz A, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GN. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20(1):17-23, 2002. e-Pub 2002. PMID: 11773149.
Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KK. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51:671-8, 2001. e-Pub 2001. PMID: 11597808.
Perkins GH, McNeese MD, Antolak JA, Buchholz TA, Strom EA, Hogstrom KR. A custom three-dimensional electron bolus technique for optimization of postmastectomy irradiation. Int J Radiat Oncol Biol Phys 51:1142-51, 2001. e-Pub 2001. PMID: 11704339.

Invited Articles

Buchholz TA, Tucker SL, Katz A, McNeese MD, Strom EA, Perkins GH, Buzdar AU, Kuerer HM, Hunt KK, Singletary SE, Sahin AA, Thames HD, Meric FA, Masullo L, Hortobagyi GN. Factors Predictive For Local-regional Recurrence After Neoadjuvant Chemotherapy and Mastectomy: Implication for Radiation Treatment. Am J Oncol Review 1(1):13-16, 2002. e-Pub 2002.
Buchholz TA, Strom EA, Perkins GH, McNeese MD. Controversies regarding the use of radiation after mastectomy in breast cancer. Oncologist 7(6):539-46, 2002. e-Pub 2002. PMID: 12490741.

Review Articles

Gonzalez-Angulo AM, Walters RS, Carpenter RJ, Jr, Ross MI, Perkins GH, Gwyn K, Theriault RL. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 5(4):317-9, 2004. e-Pub 2004. PMID: 15507181.
Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Advances in radiation treatments of breast cancer. Clin Breast Cancer 4(6):401-6, 2004. e-Pub 2004. PMID: 15023240.
Middleton LP, Chen V, Perkins GH, Pinn V, Page D. Histopathology of breast cancer among African-American women. Cancer 97(1 Suppl):253-7, 2003. e-Pub 2003. PMID: 12491489.

Editorials

Perkins GH, Middleton LP. Breast cancer in men. BMJ 327(7409):239-40, 2003. PMID: 12896911.
Perkins GH, Middleton LP. Male breast carcinoma: Declarations, solemn submissions. BMJ 327:239-240, 2003.
Perkins GH, Middleton LP, Buchholz TA. Male breast carcinoma: Improving outcomes with optimal local-regional therapy. Breast Disease 14, 2003.

Abstracts

Shaitelman SF, Gandhi A, Xu T, DeSnyder S, Smith GL, Lin R, Barcenas C, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I. Prospective, Longitudinal Assessment of Lymphedema-related Quality of Life for Locally Advanced Breast Cancer Patients: A Foundation for Needed Elements in a Lymphedema Screening Program. American Radium Society 2022 Annual Meeting, 2022. e-Pub 2022.
DPasalic, EAStrom, PKAllen, TWilliamson, FPoenisch, RAAmos, WAWoodward, MCStauder, SFShaitelman, BDSmith, GHPerkins, WTereffe, KEHoffman. Prospectively Assessed Outcomes for Proton Accelerated Partial Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics 105(1, Supplement):S193, 2019.
Christopherson KM, Lei X, Barcenas CH, Buchholz TA, Hoffman KE, Kuerer HM, Mittendorf EA, Perkins GH, Shaitelman SF, Smith GL, Stauder MC, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Breast cancer patients presenting with Sternal or Mediastinal involvement. International Journal of Radiation Oncology 99(2):E10-E11, 2017. e-Pub 2017.
Woodward WA, Arriaga L, Gao H, Cohen E, Li L, Reuben JM, Munsell M, Boglio K, Valero V, Petross L, Middleton LP, Strom EA, Tereffe W, Hoffman K, Smith B, Buchholz TA, Perkins GH. Prospective phase II study of concurrent Capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer. Proceedings of the San Antonio Breast Cancer Symposium, 2014. e-Pub 2014.
Yu TK, Carkaci S, Strom EA, Perkins GH, Tereffe W, Woodward WA, Oh JL, Rohren EM, Cristofanilli M, Yang WT, Buchholz TA. FDG-PET response of lymph nodes to neoadjuvant chemotherapy for locally advanced breast cancer does not correlate with pathologic response. Oncology 24(4, S3):1, 2010. e-Pub 2010.
Woodward WA, Beadle BM, Meric-Bernstam F, Strom EA, Tereffe W, Yu TK, Oh JL, Perkins GH, Buchholz TA. Locoregional recurrence in young women with node-negative breast cancer treated with mastectomy, axillary lymph node evaluation and adjuvant chemotherapy. Oncology 23(4(S2)):4, 2009. e-Pub 2009.
Zhang Y, Oh JL, Whitman G, Iyengar P, Yu T, Tereffe W, Woodward WA, Perkins GH, Buchholz TA, Strom EA. Clinically apparent internal mammary nodal involvement in patients with advanced breast cancer - incidence, treatment and outcome. Proceedings of the American Society for Therapeutic Radiology and Oncology 50th Annual Meeting, Int J Radiat Oncol Biol Phys 72(1):S155, 2008. e-Pub 2008.
Woodward WA, Beadle BM, Oh JL, Tereffe W, Litton JK, Perkins GH, Strom EA, Yu T, Meric-Bernstam F, Buchholz TA. Significant improvement in regional recurrence in young patients with breast cancer treated with comprehensive nodal irradiation. Proceedings of the American Society for Therapeutic Radiology and Oncology, Int J Radiat Oncol Biol Phys 72(1):S89, 2008. e-Pub 2008.
Perkins GH, Middleton LP, Tran R, Garcia SM, Cristofanilli M, Pusztai L, Singletary SE, Strom EA, l Woodward WA, Yu TK, Oh JL, Tereffe W, Whitman GJ, Huang E, Allen PK, Buchholz TA. Concurrent chemoradiation with capecitabine achieves meritable response and local control for inoperable and recurrent neoadjuvant chemotherapy refractory breast cancer. Breast CA Res Treat, 2007. e-Pub 2007.
Oh JL, Symmans WF, Woodward WA, Tereffe W, Tk Y, Strom EA, Perkins GH, Buchholz TA. Pathologic response to neoadjuvant chemotherapy and radiation therapy to improve locoregional control. Oncology 21(5)S2:8, 2007. e-Pub 2007.
Woodward WA, Arriaga L, Domain D, Strom EA, Perkins GH, Yu TK, Oh JL, Tereffe W, Lucci A, Buchholz TA. Prospective evaluation of late, chronic lymphedema (LE) after axillary lymph node dissection (ALND) and comprehensive irradiation. Oncology 21(5)S2:9, 2007. e-Pub 2007.
Oh JL, Nguyen G, Whitman GJ, Hunt KK, Woodward WA, Yu T, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placements of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy improves local control. Int J Radiat Oncol Biol Phys 69(3):S71-S72, 2007. e-Pub 2007.
Greenbaum MP, Strom EA, Allen PK, Perkins GH, Oh JL, Tereffe W, Yu KT, Buchholz TA, Woodward WA. Locoregional recurrence (LRR) before and after implementation of computed tomography (CT)-based treatment planning in post-mastectomy radiation therapy (PMRT). Int J Radiat Oncol Biol Phys 69(3):S223-S224, 2007. e-Pub 2007.
Gl S, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Oh JL, Tereffe W, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 69(3):S217-S218, 2007. e-Pub 2007.
Beadle BM, Woodward WA, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu T, Meric-Bernstam F. Locoregional recurrence rates in young women with breast cancer by treatment approach. Int J Radiat Oncol Biol Phys 69(3):S213, 2007. e-Pub 2007.
Reed V, Woodward W, Zhang L, Strom E, Perkins G, Tereffe W, Yu T, Oh J, Whitman G, Dong J. Delineating whole breast contouring variation using standard planning tools versus deformable image registration. Int J Radiat Oncol Biol Phys 69(3):S139-S140, 2007. e-Pub 2007.
Allen MW, Perkins GH, Cantor SB. A cost-effectiveness analysis of raloxifene in the prevention of invasive breast cancer in women treated for Hodgkin's Disease. 1st annual American Society for Therapeutic Radiology and Oncology Health Services Research Symposium, 2006. e-Pub 2006.
Chandwani KD, Thornton B, Perkins GH, Rivera EG, Arun B, Raghuram NV, Nagendra HR, Cohen L. Randomized trial of yoga in women with breast cancer undergoing radiationtreatment: improved quality of life with yoga therapy. American Psychosomatic Society Conference (poster), 2006. e-Pub 2006.
Cohen L, Chandwani KD, Perkins GH, Rivera EG, Arun B, Raghuran NV, Nagendra HR, Gritz E. Yoga therapy in breast radiation: a randomized trial. J Clin Oncol 24, 2006. e-Pub 2006.
Chandwani KD, Thornton B, Perkins GH, Rivera E, Arun B, Raghuram NV, Nagendra HR, Cohen L. Randomized trial of yoga in women with breast cancer undergoing comprehensive radiation treatment. Proceedings of the International Psycho-oncology Society, 2005. e-Pub 2005.
Perkins GH, Middleton LP, Tran RT, Garcia SM, Buchholz TA. Tubular carcinoma: outcomes analysis of favorable breast cancer treated with breast conserving therapy. Proceedings of the 28th annual San Antonio Breast Cancer Symposium, Breast Ca Res Treat (abstract poster discussion 4032, 2005. e-Pub 2005.
Chandwani KD, Thornton B, Perkins GH, Rivera E, Arun B, Raghuram NV, Nagendra HR, Cohen L. Randomized trial of yoga in women with breast cancer. Proceedings of the 2nd International Conference of teh Society of Integrative Oncology, 2005. e-Pub 2005.
Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of local-regional reucrrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Proceedings fo the American Society for Therapeutic Radiology and Oncology 47th Annual Meeting. Int J Rad Oncol Biol Phys 63(2):S250, 2005. e-Pub 2005.
Garg AK, Oh JL, Oswald M, Huang EH, Strom EA, Perkins GH, Meric-Bernstam F, Gwynn K, Buchholz TA. Postmastectomy radiation therapy in stage II-III breast cancer patients <35 years old treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Proceedings of the American Society for Therapeutic Radiology and Oncology 47th Annual Meeting. Int J Rad Oncol Biol Phys 63(2):S250, 2005. e-Pub 2005.
Woodward WA, Durand J, Tucker SL, Strom EA, Perkins GH, Oh JL, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid flow in breast cancer patients treated with supraclavicualr irradiation eight or more years prior to study: no increase in ipsilateral carotid stenosis after radiation. Proceedings of the American Society for Therapeutic Radiology and Oncology 47th Annual Meeting. Int J Rad Oncol Biol Phys 63(2):S236, 2005. e-Pub 2005.
Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh JL, Domain D, Singletary SE, Buzdar AU, Hortobagyi GN, McNeese MD. Fifteen-year results of a randomized prospective trial comparing hyperfractionated versus once-daily chest wall radiation after chemotherapy and mastectomy for patients with locally advanced non-inflammatory breast cancer. Proceedings of the American Society for Therapeutic Radiology and Oncology 47th Annual Meeting. Int J Rad Oncol Biol Phys 63(2):S235, 2005. e-Pub 2005.
Oh JL, Strom EA, Perkins GH, Oswald M, Domain D, Hunt KK, Giordano S, Buchholz TA. Locoregional treatment after neoadjuvant chemotherapy for clinically multifocal or mulcientric breast cancer at the time of diagnosis. Proceedings of the American Society for Therapuetic Radiology and Oncology 47th Annual Meeting. Int J Rad Oncol Biol Phys 63(2):S52, 2005. e-Pub 2005.
Yom SS, Morrison WM, Ang KK, Rosenthatl DI, Perkins GH, Garden AS. Caudal tilt and three-field technique in post-operative irradiation of the had and neck. Proceedings fo the 87th annual meeting of the American Radium Society. Cancer J, 2005. e-Pub 2005.
Perkins GH, Middleton L, Sahin AA, Singletary SE. Isolated LCIS after core needle biopsy: is Tamoxifen a rational chemoprevention choice?. J Clin Oncol 24 (asbtract 1012):105-106, 2005. e-Pub 2005.
McGuire SE, Gonzales-Angulo AM, Tucker SL, Rouzier R, Strom EA, Perkins GH, Oh JL, Huang EH, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Radiation is an important component of therapy for patients with stage III breast cancer who achieve a pathological complete response after neoadjuvant chemotherapy. Int J Rad Oncol Biol Phys 63(2):S52, 2005. e-Pub 2005.
Morandi P, Middleton LP, Mirza NQ, Vlastos G, Kau S, Perkins GH, Kuerer HM, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M. Occult breast cancer (OBC), a retrospective analysis of clinico-pathological characteristics and long-term outcome: The University of Texas M.D. Anderson Cancer Center experience. Br CA Res Treat (in press), 2004. e-Pub 2004.
Perkins GH, Green MD, Middleton LP, Giordano SH, Garcia SM, Strom EA, Nr S, Allen PA, Buchholz TA, Hortobagyi GN. Medullary breast carcinoma: outcomes and prognosis with the utilization of chemotherapy. J Clin Oncol 23:44-45, 2004. e-Pub 2004.
Gupta DA, Perkins GH, Garcia SM, Sahin AA, Middleton LP. Male breast cancer: clinico-pathological study with evaluation of biologic markers. J Clin Oncol 23:70-71 (Abstract 777), 2004. e-Pub 2004.
Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD Kuerer H, Ross MI, Singletary SE, Ames F, Feig BW, Sahin AA, Perkins GH, Schechter NR, Barbiera G, Hortobagyi GN, Buchholz TA. Breast Conservation after Neoadjuvant Chemotherapy: A Prognostic Index for Clinical Decision-Making. Proceedings of the 86th Annual Meeting of the American Radium Society, Cancer J 10, 2004. e-Pub 2004.
Buchholz TA, Woodward WA, Tucker SL, Strom EA, Hunt KK, Buzdar AU, Perkins GH, Schechter NR, Hortobagyi GN. Defining the competing risk of local-regional and distant recurrence in 1256 patients treated with mastectomy and doxorubicin-based adjuvant chemotherapy. J Clin Oncol 23:15-16 (Abstract 555), 2004. e-Pub 2004.
Schechter NR, Strom EA, Perkins GH, Arzu IY, McNeese MD, Buchholz TA. The Impact of Immediate Breast Reconstruction (IBR) on Post Mastectomy Radiation Therapy (PMRT) Technique. Proceedings of the 86th Annual Meeting of the American Radium Society, Cancer J 10, 2004. e-Pub 2004.
Perkins GH, Middleton LP, Strom EA, Garcia SM, Schechter NS, Buchholz TA. Medullary breast carcinoma: outcomes analysis of treatment with and without breast conservation therapy. Proceedings of the 86th Annual Meeting of the American Radium Society, Cancer J 10, 2004. e-Pub 2004.
Perkins GH, Green MC, Middleton LP, Giordano SH, Garcia SM, Strom EA, Schechter NR, Allen PA, Buchholz TA, Hortobagyi GN. Medullary breast carcinoma: outcomes and prognosis with the utilization of chemotherapy. J Clin Oncol 23:44-45 (Abstract 671), 2004. e-Pub 2004.
Thornton B, Chaoul-Reich A, Perkins GH, Chandwani K, Tare V, Sterner J, Cohen L. A randomized trial of tibetan yoga intervention for breast cancer patients. Proceedings fo the 1st Annual Meeting of the Society of Integrative Oncology. Cancer, 2004. e-Pub 2004.
Huang E, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Hunt KK, Sahin A, Buchholz TA. Radiation treatment reduces local-regional recurrence and improves survival in selected breast cancer patients treated with neoadjuvant chemotherapy and mastectomy. Int J Radiat Onco Biol Phys 57:S328, 2003. e-Pub 2003.
Yu TK, Whitman GJ, Thames HD, Strom EA, McNeese MD, Perkins GH, Schechter N, Kau SW, Buzdar AU, Hortobagyi GH, Thomas ES, Buchhola TA. Clinically-relevant pneumonitis is not increased in breast cancer patients treated with sequential paclitaxel and radiation. Int J Radiat Onco Biol Phys 57:S127-8, 2003. e-Pub 2003.
Bonnen MD, Outlaw ED, McNeese MD, Thames HD, Strom EA, Perkins GH, Schechter NR, Romaine Z, Hortobagyi GN, Theriault RL, Hunt KK, Buchholz TA. Factors associated with breast recurrence in young females treated with breast conservation therapy: how young is young? . Int J Radiat Onco Biol Phys 57:S356-7, 2003. e-Pub 2003.
Buchholz TA, Huang E, Berry D, Strom EA, McNeese MD, Pusztai L, Kuerer HM, Buzdar AU, Hortobagyi GH, Valero V, Perkins GH, Sahin AA. Her2-Neu overexpression does not increase the risk of local-regional recurrence for patients treated with neoadjuvant Doxorubicin-based chemotherapy, mastectomy, and radiation. Int J Radiat Onco Biol Phys 57:S201, 2003. e-Pub 2003.
Giordano S, Perkins GH, Cohen D, Buzdar A, Hortobagyi GN. A population-based analysis of male breast cancer. Proceedings for the 39th Annual Meeting of the American Society of Clinical Oncology. JCO 21, 2003. e-Pub 2003.
Woodward WA, Strom EA, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 AJCC staging for breast cancer dramatically affects stage-specific survival. Proceedings for the 39th Annual Meeting of the American Society of Clinical Oncology. JCO 21, 2003. e-Pub 2003.
Giordano SH, Perkins GH, Buzdar AU, Hortobagyi GN. Male Breast Cancer: The MD Anderson Experience with Adjuvant Systemic Therapy. Proceedings of the 26th Annual San Antonio Breast Cancer Symposium, Breast Cancer Res Treat 82:S42-S43 (Abstract 177), 2003. e-Pub 2003.
Chandra A, Perkins GH, Kim E, Shin DM, Middleton LP, Liao Z, Garcia SM, Castro C, Ro JY, Walsh GL, Putnam JB, Roth JA, Allen PK, Cox JD, Komaki R. The addition of chemotherapy to surgery and radiation improves outcome in the treatment of invasive thymoma. Proceedings for the 85th Annual Meeting of the American Radium Society. The Ca J, 2003. e-Pub 2003.
Woodward WA, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Buchholz TA. Long-term toxicity after postmastecomy radiation and doxorubicin-based chemotherapy. Proceedings for the 85th Annual Meeting of the American Radium Society. The Ca J, 2003. e-Pub 2003.
Chen AM, Meric F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig B, Hortobagyi GN, Sahin AA, Perkins GH, Schechter NR, Buchholz TA. Breast-conserving therapy after neoadjuvant chemotherapy: The M. D. Anderson Cancer Center experience. Breast Cancer Res Treat 82:S7-S8, (Abstract #6), 2003. e-Pub 2003.
Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA. Predictors of local-regional recurrence in patients with locally-advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiation. Breast Cancer Res Treat 82:S182, (Abstract #1045), 2003. e-Pub 2003.
Garden AS, Morrison WH, Wong P, Tung S, Rosenthal DI, Schechter NR, Perkins GH, Ang KK. Preliminary results of intensity modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 57:S407, 2003. e-Pub 2003.
Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Schechter NR, Middleton LP, Hunt KK, Hortobagyi GN, Gwyn KM, Buchholz TA. African-American patients with breast cancer have worse overall survival than Caucasian and Hispanic patients after mastectomy and doxorubicin-based chemotherapy: data from two independent data sets . Breast Cancer Res Treat 82:S145-S146, (Abstract #613), 2003. e-Pub 2003.
Perkins GH, Liao Z, Kim E, Middleton LP, Garcia SM, Castro C, Ro JY, Roth JA, Allen PK, Cox JD, Komaki R. Thymic neoplasms: An outcomes analysis of 78 patients treated at M. D. Anderson Cancer Center. Proceedings for the 85th Annual Meeting of the American Radium Society. The Ca J, 2003. e-Pub 2003.
Yu T, Whitman GJ, Thames HD, Strom E, McNeese MD, Perkins GH, Schechter N, Kau S, Buzdar AU, Hortobagyi GN, Thomas E, Buchholz TA. Clinically-relevant pneumonitis is not increased in breast cancer patients treated with sequential paclitaxel and radiation. Int J Radiat Oncol Biol Phys 57:S127-8, 2003. e-Pub 2003.
Arzu I, Perkins GH, Antolak J, Kirshner S, Levy L, Strom EA, McNeese MD, Buchholz TA. Field-in-field tangent technique improves dose homogeneity in breast conservation. Proceedings for the 85th Annual Meeting of the American Radium Society. The Ca J, 2003. e-Pub 2003.
Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Factors predictive of having four or more positive axillary lymph nodes in patients with involved sentinel lymph nodes: implications for selection of radiation treatment fields. Breast Cancer Res Treat 82:S182, (Abstract #1046), 2003. e-Pub 2003.
Garg A, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Schechter N, Sahin AA, Valero V, Tucker SL, Buchholz TA. Clinical stage T3 disease or pathologic involvement of four or more lymph nodes predict for local-regional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiation . Breast Cancer Res Treat 82:S182-S183, (Abstract #1047), 2003. e-Pub 2003.
Giordano SH, Perkins GH, Garcia SM, Middleton LP, Buzdar AU, Hortogabyi GN. Male breast carcinoma: Outcomes of adjuvant therapy utilization at M. D. Anderson Cancer Center. Proceedings for the 26th Annual San Antonio Breast Cancer Symposium, Breast Ca Res Treat (In press), 2003. e-Pub 2003.
Gupta D, Perkins GH, Garcia SM, Sahin AA, Middleton LP. Carcinoma of the male breast: A single institution clinicopathological study. Proceedings of the International Academy of Pathology, 2002. e-Pub 2002.
Woodward WA, Katz A, Buchholz TA, McNeese MD, Perkins GH, Jhingran A, Strom EA. Patterns and predictors of locoregional recurrence in 469 patients treated with post-mastectomy radiation. Proceedings of the 44th Annual ASTRO meeting. Int J Radiat Oncol Biol Phys 54:91-92, 2002. e-Pub 2002.
Perkins GH, Middleton LP, Garcia SM, Strom EA, McNeese MD, Kuerer HM, Singletary SE, Hunt KK, Whitman GW, Hortobagyi GN, Buchholz TA. Male breast Carcinoma: outcomes and predictors in patients treated without radiation therapy. Proceedings of the 25th Annual San Antonio Breast Cancer Symposium, Breast Ca Res Treat 76:121-122, 2002. e-Pub 2002.
Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Thames HD, Kuerer HM, Hortobaygi GN, Hunt KK, Tucker SL. Comparison of Pathological Risk Factors for Postmastectomy Local-regional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy for Patients Not Treated With Radiation. Proceedings of the 43rd Annual ASTRO Meeting. Int J Radiat Biol Oncol Phys 51:107, 2001. e-Pub 2001.
Buchholz TA, Tucker SL, Masullo L, Kurer HM, Enron J, Perkins GH, Salas-Gonzales JStrom EA, McNeese MD, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GN. Predictors of Local-regional recurrence following neoadjuvant chemotherapy and mastectomy. Proceedings for the 83rd Annual Meeting of the American Radium Society, 2001. e-Pub 2001.
Meric F, Buchholz TA, Mirza NQ, Vlastos G, Singletary SE, Ross MI, Ames FC, Pollack RE, Feig BW, Newman LA, Perkins GH, Strom EA McNeese MD, Hortobagyi GN, Hunt KK. Complications of breast conservation surgery and radiation therapy. Proceedings of the 6th Annual San Antonio Breast Cancer Symposium Meeting, 2000. e-Pub 2000.
Meric F, Buchholz TA, Perkins GH, Mirza NQ, Vlastos G, Singletary SE, Ross MI, Ames FC, Pollack RE, Feig BW, Newman LA, Strom EA McNeese MD, Hortobagyi GN, Hunt KK. Long term complications after breast conservation surgery and radiation therapy. Proceedings of The American Society of Breast Surgeons Annual Meeting, 2000. e-Pub 2000.
Perkins GH, Schomer DA, Fuller GF, Allen PA, Maor MH. Gliomatosis Cerebri: Improved Results with Radiation Therapy. Proceedings of the 82 Annual Meeting of The American Radium Society, 2000. e-Pub 2000.
Perkins GH, McNeese MD, Antolak JA, Strom EA, Buchholz TA, Hogstrom KR. Custom Three Dimensional Electron Bolus Technique for Optimization of Post Mastectomy Irradiation. Proceedings of the first Annual Meeting of The American Society of Breast Surgeons, 2000. e-Pub 2000.

Book Chapters

Perkins GH, Middleton LP. Tubular, Mucinous, and Medullay Carcinoma. In: Advanced Therapy of Breast Disease. 3rd. People's Medical Publishing House, 1097-1108, 2012.
Janjan N, Strom EA, Perkins GH, Ha C, Chang JY. Effects of radiation on the heart. In: Cancer and the Heart. BC Decker, 75-114, 2006.

Less

CV information above last modified August 03, 2026

George H. Perkins, MD

About Dr. George H. Perkins

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

George H. Perkins, MD

About Dr. George H. Perkins

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson